TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
B/P-Pharma AB
Closing information (x1000 DKK)
| Closing information | 2023/04 | 2022/04 | 2021/04 |
| Turnover |
8,345
|
8,541
|
8,592 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
219
|
229
|
118 |
| EBITDA |
354
|
235
|
130 |
| Total assets |
3,376
|
3,388
|
3,488 |
| Current assets |
2,840
|
3,368
|
3,462 |
| Current liabilities |
965
|
945
|
1,197 |
| Equity capital |
2,246
|
2,276
|
2,128 |
| - share capital |
33
|
36
|
37 |
| Employees (average) |
3
|
3
|
3 |
Financial ratios
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Solvency |
66.5%
|
67.2%
|
61.0% |
| Turnover per employee |
2,782
|
2,847
|
2,864 |
| Profit as a percentage of turnover |
2.6%
|
2.7%
|
1.4% |
| Return on assets (ROA) |
6.5%
|
6.8%
|
3.4% |
| Current ratio |
294.3%
|
356.4%
|
289.2% |
| Return on equity (ROE) |
9.8%
|
10.1%
|
5.5% |
| Change turnover |
556
|
74
|
119 |
| Change turnover % |
7%
|
1%
|
1% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/04 | 2022/04 | 2021/04 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.